NCT03797963 is a NA clinical trial of PBM+ACB in Sinus Floor Augmentation, sponsored by Universidad de Granada.

Who is sponsoring NCT03797963?

NCT03797963 is sponsored by Universidad de Granada.

What drugs are being tested in NCT03797963?

Interventions in NCT03797963: PBM+ACB, ABB+ACB.

What condition does NCT03797963 study?

NCT03797963 studies Sinus Floor Augmentation.

Is NCT03797963 still recruiting?

NCT03797963 is currently completed. Last updated 23 May 2023.

Last reviewed 2023-05-23 · How we verify

NCT03797963

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study on the Use of Symbios Xenograft for Sinus Floor Elevation

Completed NA Last updated 23 May 2023

What this trial tests

NA trial testing PBM+ACB in Sinus Floor Augmentation in 10 participants. Completed in 27 February 2022.

Timeline

8 January 2019

Primary endpoint
2 February 2021

27 February 2022

Quick facts

Lead sponsor	Universidad de Granada
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	10
Start date	8 January 2019
Primary completion	2 February 2021
Estimated completion	27 February 2022
Sites	1 location across Spain

Drugs / interventions tested

PBM+ACB
ABB+ACB

Conditions studied

Sinus Floor Augmentation — all drugs for Sinus Floor Augmentation →

Sponsor

Universidad de Granada — full company profile →

Who can join

18 and older, any sex, with Sinus Floor Augmentation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the clinical and radiological behavior, the histological and morphometrical components, the expression of proteins related to bone formation, and the analysis of markers of reparative mesenchymal stromal cells, after using two different xenogenic biomaterials in combination with autogenous cortical bone for maxillary sinus floor elevation. A randomized split-mouth clinical study is designed to include patients in need of two-stage bilateral maxillary sinus floor elevation. Patients will be assigned to receive a mix of autogenous cortical bone (collected by a bone scraper from the access window to the maxillary sinus) and anorganic bovine bone (BioOss Xenograft) in one maxillary sinus or autogenous cortical bone and porcine bone mineral (Symbios Xenograft) in the other maxillary sinus. Cone-beam computerized tomography (CBCT) scans will be performed before and after sinus floor elevation and 6, 12 and 18 months after the procedure to assess the bone gain. Bone core biopsies will be obtained at the site of implant placement 6 months after the floor elevation. Histological sections will be subjected to histomorphometric and immunohistochemical evaluation of differentiation markers.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Maxillary sinus floor augmentation comparing bovine versus porcine bone xenografts mixed with autogenous bone graft. A split-mouth randomized controlled trial.
Galindo-Moreno P, Abril-García D, Carrillo-Galvez AB, Zurita F, et al · · 2022 · cited 29× · PMID 35224778 · DOI 10.1111/clr.13912
Bone Regeneration Using Mesenchymal Stromal Cells and Biocompatible Scaffolds: A Concise Review of the Current Clinical Trials.
Re F, Borsani E, Rezzani R, Sartore L, et al · · 2023 · cited 21× · PMID 37232981 · DOI 10.3390/gels9050389

Verify or expand the search:

Other recruiting trials for Sinus Floor Augmentation

Currently open trials in the same condition.

NCT07526337 — Digital Planning and Clinical Assessment of the Treated Atrophic Posterior Maxilla With a Sinus Lift Procedure: a Cross- · recruiting
NCT07526129 — Impact of Alveolar Ridge Preservation on the Potential Need for Sinus Floor Elevation: A 10-year Retrospective Radiograp · recruiting
NCT05315791 — Clinical Application Strategies of Maxillary Sinus Buccal Bony Window · NA · recruiting

Other Universidad de Granada trials

Trials by the same sponsor.

NCT07497698 — Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults · NA · recruiting
NCT07528924 — TuJugling: Comparing Two Juggling Learning Methods in College Students · NA · recruiting
NCT07388134 — Virtual Reality Based High-intensity Interval Training in Chronic Low Back Pain · NA · active not recruiting
NCT07494916 — Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia · NA · active not recruiting
NCT06518200 — Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03797963 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Granada
Last refreshed: 23 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03797963.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing